Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

N-Acyl-O-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann-Pick C1 disease.

Sidhu R, Mondjinou Y, Qian M, Song H, Kumar AB, Hong X, Hsu FF, Dietzen DJ, Yanjanin NM, Porter FD, Berry-Kravis E, Vite CH, Gelb MH, Schaffer JE, Ory DS, Jiang X.

J Lipid Res. 2019 Jun 14. pii: jlr.RA119000157. doi: 10.1194/jlr.RA119000157. [Epub ahead of print]

2.

A cross-species approach to disorders affecting brain and behaviour.

Devinsky O, Boesch JM, Cerda-Gonzalez S, Coffey B, Davis K, Friedman D, Hainline B, Houpt K, Lieberman D, Perry P, Prüss H, Samuels MA, Small GW, Volk H, Summerfield A, Vite C, Wisniewski T, Natterson-Horowitz B.

Nat Rev Neurol. 2018 Nov;14(11):677-686. doi: 10.1038/s41582-018-0074-z. Review.

3.

Accuracy of TomoEDGE dynamic jaw field widths.

Urso P, Corradini NA, Vite C.

J Appl Clin Med Phys. 2018 Sep;19(5):761-766. doi: 10.1002/acm2.12418. Epub 2018 Jul 29.

4.

Quantitative DTI metrics in a canine model of Krabbe disease: comparisons versus age-matched controls across multiple ages.

Li JY, Middleton DM, Chen S, White L, Corado CR, Vite C, Bradbury A, Provenzale JM.

Neuroradiol J. 2018 Apr;31(2):168-176. doi: 10.1177/1971400917733431. Epub 2018 Jan 19.

5.

LC3 Immunostaining in the Inferior Olivary Nuclei of Cats With Niemann-Pick Disease Type C1 Is Associated With Patterned Purkinje Cell Loss.

Gurda BL, Bagel JH, Fisher SJ, Schultz ML, Lieberman AP, Hand P, Vite CH, Swain GP.

J Neuropathol Exp Neurol. 2018 Mar 1;77(3):229-245. doi: 10.1093/jnen/nlx119.

6.

AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease).

Bradbury AM, Rafi MA, Bagel JH, Brisson BK, Marshall MS, Pesayco Salvador J, Jiang X, Swain GP, Prociuk ML, ODonnell PA, Fitzgerald C, Ory DS, Bongarzone ER, Shelton GD, Wenger DA, Vite CH.

Hum Gene Ther. 2018 Jul;29(7):785-801. doi: 10.1089/hum.2017.151. Epub 2018 Mar 14.

7.

Canine and Feline Models of Human Genetic Diseases and Their Contributions to Advancing Clinical Therapies
.

Gurda BL, Bradbury AM, Vite CH.

Yale J Biol Med. 2017 Sep 25;90(3):417-431. eCollection 2017 Sep. Review.

8.

Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals.

Hinderer C, Bell P, Katz N, Vite CH, Louboutin JP, Bote E, Yu H, Zhu Y, Casal ML, Bagel J, O'Donnell P, Wang P, Haskins ME, Goode T, Wilson JM.

Hum Gene Ther. 2018 Jan;29(1):15-24. doi: 10.1089/hum.2017.026. Epub 2017 Oct 3.

9.

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial.

Ory DS, Ottinger EA, Farhat NY, King KA, Jiang X, Weissfeld L, Berry-Kravis E, Davidson CD, Bianconi S, Keener LA, Rao R, Soldatos A, Sidhu R, Walters KA, Xu X, Thurm A, Solomon B, Pavan WJ, Machielse BN, Kao M, Silber SA, McKew JC, Brewer CC, Vite CH, Walkley SU, Austin CP, Porter FD.

Lancet. 2017 Oct 14;390(10104):1758-1768. doi: 10.1016/S0140-6736(17)31465-4. Epub 2017 Aug 10.

10.

Novel region of interest interrogation technique for diffusion tensor imaging analysis in the canine brain.

Li JY, Middleton DM, Chen S, White L, Ellinwood NM, Dickson P, Vite C, Bradbury A, Provenzale JM.

Neuroradiol J. 2017 Aug;30(4):339-346. doi: 10.1177/1971400917709629. Epub 2017 Jun 19.

11.

Fostering collaborative research for rare genetic disease: the example of niemann-pick type C disease.

Walkley SU, Davidson CD, Jacoby J, Marella PD, Ottinger EA, Austin CP, Porter FD, Vite CH, Ory DS.

Orphanet J Rare Dis. 2016 Dec 1;11(1):161.

12.

Temporal behavior of seizures and interictal bursts in prolonged intracranial recordings from epileptic canines.

Ung H, Davis KA, Wulsin D, Wagenaar J, Fox E, McDonnell JJ, Patterson N, Vite CH, Worrell G, Litt B.

Epilepsia. 2016 Dec;57(12):1949-1957. doi: 10.1111/epi.13591. Epub 2016 Nov 3.

13.

Diffusion tensor imaging analysis of the brain in the canine model of Krabbe disease.

Bradbury A, Peterson D, Vite C, Chen S, Ellinwood NM, Provenzale J.

Neuroradiol J. 2016 Dec;29(6):417-424. Epub 2016 Sep 27.

14.

Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).

Bradbury AM, Bagel JH, Jiang X, Swain GP, Prociuk ML, Fitzgerald CA, O'Donnell PA, Braund KG, Ory DS, Vite CH.

J Neurosci Res. 2016 Nov;94(11):1007-17. doi: 10.1002/jnr.23838.

15.

Insights into the Pathogenesis and Treatment of Krabbe Disease.

Bongarzone ER, Escolar ML, Gray SJ, Kafri T, Vite CH, Sands MS.

Pediatr Endocrinol Rev. 2016 Jun;13 Suppl 1:689-96. Review.

PMID:
27491217
16.

Cerebrospinal Fluid Calbindin D Concentration as a Biomarker of Cerebellar Disease Progression in Niemann-Pick Type C1 Disease.

Bradbury A, Bagel J, Sampson M, Farhat N, Ding W, Swain G, Prociuk M, O'Donnell P, Drobatz K, Gurda B, Wassif C, Remaley A, Porter F, Vite C.

J Pharmacol Exp Ther. 2016 Aug;358(2):254-61. doi: 10.1124/jpet.116.232975. Epub 2016 Jun 15.

17.

Correction: Forecasting Seizures Using Bivariate Intracranial EEG Measures and SVM in Naturally Occurring Canine Epilepsy.

Brinkmann BH, Patterson EE, Vite C, Vasoli VM, Crepeau D, Stead M, Howbert JJ, Cherkassky V, Wagenaar JB, Litt B, Worrell GA.

PLoS One. 2016 May 26;11(5):e0156476. doi: 10.1371/journal.pone.0156476. eCollection 2016.

18.

Crowdsourcing reproducible seizure forecasting in human and canine epilepsy.

Brinkmann BH, Wagenaar J, Abbot D, Adkins P, Bosshard SC, Chen M, Tieng QM, He J, Muñoz-Almaraz FJ, Botella-Rocamora P, Pardo J, Zamora-Martinez F, Hills M, Wu W, Korshunova I, Cukierski W, Vite C, Patterson EE, Litt B, Worrell GA.

Brain. 2016 Jun;139(Pt 6):1713-22. doi: 10.1093/brain/aww045. Epub 2016 Mar 31.

19.

Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease.

Nicoli ER, Al Eisa N, Cluzeau CV, Wassif CA, Gray J, Burkert KR, Smith DA, Morris L, Cologna SM, Peer CJ, Sissung TM, Uscatu CD, Figg WD, Pavan WJ, Vite CH, Porter FD, Platt FM.

PLoS One. 2016 Mar 28;11(3):e0152007. doi: 10.1371/journal.pone.0152007. eCollection 2016.

20.

Ebola virus mediated infectivity is restricted in canine and feline cells.

Han Z, Bart SM, Ruthel G, Vande Burgt NH, Haines KM, Volk SW, Vite CH, Freedman BD, Bates P, Harty RN.

Vet Microbiol. 2016;182:102-7. doi: 10.1016/j.vetmic.2015.11.011. Epub 2015 Nov 17.

21.

Diffusion Tensor Imaging for Assessing Brain Gray and White Matter Abnormalities in a Feline Model of α-Mannosidosis.

Kumar M, Duda JT, Yoon SY, Bagel J, O'Donnell P, Vite C, Pickup S, Gee JC, Wolfe JH, Poptani H.

J Neuropathol Exp Neurol. 2016 Jan;75(1):35-43. Erratum in: J Neuropathol Exp Neurol. 2017 Feb 1;76(2):158.

22.

Mining continuous intracranial EEG in focal canine epilepsy: Relating interictal bursts to seizure onsets.

Davis KA, Ung H, Wulsin D, Wagenaar J, Fox E, Patterson N, Vite C, Worrell G, Litt B.

Epilepsia. 2016 Jan;57(1):89-98. doi: 10.1111/epi.13249. Epub 2015 Nov 26.

23.

Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.

Gurda BL, De Guilhem De Lataillade A, Bell P, Zhu Y, Yu H, Wang P, Bagel J, Vite CH, Sikora T, Hinderer C, Calcedo R, Yox AD, Steet RA, Ruane T, O'Donnell P, Gao G, Wilson JM, Casal M, Ponder KP, Haskins ME.

Mol Ther. 2016 Feb;24(2):206-216. doi: 10.1038/mt.2015.189. Epub 2015 Oct 8.

24.

Clinical Improvement of Alpha-mannosidosis Cat Following a Single Cisterna Magna Infusion of AAV1.

Yoon SY, Bagel JH, O'Donnell PA, Vite CH, Wolfe JH.

Mol Ther. 2016 Feb;24(1):26-33. doi: 10.1038/mt.2015.168. Epub 2015 Sep 10.

25.

Forecasting Seizures Using Intracranial EEG Measures and SVM in Naturally Occurring Canine Epilepsy.

Brinkmann BH, Patterson EE, Vite C, Vasoli VM, Crepeau D, Stead M, Howbert JJ, Cherkassky V, Wagenaar JB, Litt B, Worrell GA.

PLoS One. 2015 Aug 4;10(8):e0133900. doi: 10.1371/journal.pone.0133900. eCollection 2015. Erratum in: PLoS One. 2016;11(5):e0156476.

26.

Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.

Provenzale JM, Nestrasil I, Chen S, Kan SH, Le SQ, Jens JK, Snella EM, Vondrak KN, Yee JK, Vite CH, Elashoff D, Duan L, Wang RY, Ellinwood NM, Guzman MA, Shapiro EG, Dickson PI.

Exp Neurol. 2015 Nov;273:1-10. doi: 10.1016/j.expneurol.2015.07.021. Epub 2015 Jul 26.

27.

Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT).

Veronese I, De Martin E, Martinotti AS, Fumagalli ML, Vite C, Redaelli I, Malatesta T, Mancosu P, Beltramo G, Fariselli L, Cantone MC.

Radiat Oncol. 2015 Jun 13;10:132. doi: 10.1186/s13014-015-0438-0.

28.

Canine status epilepticus treated with fosphenytoin: A proof of principle study.

Patterson EE, Leppik IE, Coles LD, Podell M, Vite CH, Bush W, Cloyd JC.

Epilepsia. 2015 Jun;56(6):882-7. doi: 10.1111/epi.12994. Epub 2015 May 7.

29.

Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease.

Vite CH, Bagel JH, Swain GP, Prociuk M, Sikora TU, Stein VM, O'Donnell P, Ruane T, Ward S, Crooks A, Li S, Mauldin E, Stellar S, De Meulder M, Kao ML, Ory DS, Davidson C, Vanier MT, Walkley SU.

Sci Transl Med. 2015 Feb 25;7(276):276ra26. doi: 10.1126/scitranslmed.3010101.

30.

A review of gene therapy in canine and feline models of lysosomal storage disorders.

Bradbury AM, Gurda BL, Casal ML, Ponder KP, Vite CH, Haskins ME.

Hum Gene Ther Clin Dev. 2015 Mar;26(1):27-37. doi: 10.1089/humc.2015.002. Epub 2015 Feb 11. Review.

31.

Mechanism of neuromuscular dysfunction in Krabbe disease.

Cantuti-Castelvetri L, Maravilla E, Marshall M, Tamayo T, D'auria L, Monge J, Jeffries J, Sural-Fehr T, Lopez-Rosas A, Li G, Garcia K, van Breemen R, Vite C, Garcia J, Bongarzone ER.

J Neurosci. 2015 Jan 28;35(4):1606-16. doi: 10.1523/JNEUROSCI.2431-14.2015.

32.

A review of gene therapy in canine and feline models of lysosomal storage disorders.

Bradbury AM, Gurda BL, Casal ML, Ponder K, Vite C, Haskins ME.

Hum Gene Ther Clin Dev. 2015 Jan 14. [Epub ahead of print]

PMID:
25587775
33.

Aging in the canine and feline brain.

Vite CH, Head E.

Vet Clin North Am Small Anim Pract. 2014 Nov;44(6):1113-29. doi: 10.1016/j.cvsm.2014.07.008. Epub 2014 Nov 1. Review.

34.

Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).

Tortelli B, Fujiwara H, Bagel JH, Zhang J, Sidhu R, Jiang X, Yanjanin NM, Shankar RK, Carillo-Carasco N, Heiss J, Ottinger E, Porter FD, Schaffer JE, Vite CH, Ory DS.

Hum Mol Genet. 2014 Nov 15;23(22):6022-33. doi: 10.1093/hmg/ddu331. Epub 2014 Jun 25.

35.

Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis.

Fletcher JL, Kondagari GS, Vite CH, Williamson P, Taylor RM.

J Neuropathol Exp Neurol. 2014 Jun;73(6):536-47. doi: 10.1097/NEN.0000000000000075.

36.

Forecasting seizures in dogs with naturally occurring epilepsy.

Howbert JJ, Patterson EE, Stead SM, Brinkmann B, Vasoli V, Crepeau D, Vite CH, Sturges B, Ruedebusch V, Mavoori J, Leyde K, Sheffield WD, Litt B, Worrell GA.

PLoS One. 2014 Jan 8;9(1):e81920. doi: 10.1371/journal.pone.0081920. eCollection 2014.

37.

Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna.

Hinderer C, Bell P, Vite CH, Louboutin JP, Grant R, Bote E, Yu H, Pukenas B, Hurst R, Wilson JM.

Mol Ther Methods Clin Dev. 2014 Dec 10;1:14051. doi: 10.1038/mtm.2014.51. eCollection 2014.

38.

Quantitative, noninvasive, in vivo longitudinal monitoring of gene expression in the brain by co-AAV transduction with a PET reporter gene.

Yoon SY, Gay-Antaki C, Ponde DE, Poptani H, Vite CH, Wolfe JH.

Mol Ther Methods Clin Dev. 2014 Jun 4;1:14016. doi: 10.1038/mtm.2014.16. eCollection 2014.

39.

Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.

Cubizolle A, Serratrice N, Skander N, Colle MA, Ibanes S, Gennetier A, Bayo-Puxan N, Mazouni K, Mennechet F, Joussemet B, Cherel Y, Lajat Y, Vite C, Bernex F, Kalatzis V, Haskins ME, Kremer EJ.

Mol Ther. 2014 Apr;22(4):762-73. doi: 10.1038/mt.2013.283. Epub 2013 Dec 17.

40.

Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease.

Ottinger EA, Kao ML, Carrillo-Carrasco N, Yanjanin N, Shankar RK, Janssen M, Brewster M, Scott I, Xu X, Cradock J, Terse P, Dehdashti SJ, Marugan J, Zheng W, Portilla L, Hubbs A, Pavan WJ, Heiss J, Vite CH, Walkley SU, Ory DS, Silber SA, Porter FD, Austin CP, McKew JC.

Curr Top Med Chem. 2014;14(3):330-9. Review.

41.

Adeno-associated virus serotypes 9 and rh10 mediate strong neuronal transduction of the dog brain.

Swain GP, Prociuk M, Bagel JH, O'Donnell P, Berger K, Drobatz K, Gurda BL, Haskins ME, Sands MS, Vite CH.

Gene Ther. 2014 Jan;21(1):28-36. doi: 10.1038/gt.2013.54. Epub 2013 Oct 17.

42.

Feasibility study of a caregiver seizure alert system in canine epilepsy.

Coles LD, Patterson EE, Sheffield WD, Mavoori J, Higgins J, Michael B, Leyde K, Cloyd JC, Litt B, Vite C, Worrell GA.

Epilepsy Res. 2013 Oct;106(3):456-60. doi: 10.1016/j.eplepsyres.2013.06.007. Epub 2013 Aug 18.

43.

Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling.

Fan M, Sidhu R, Fujiwara H, Tortelli B, Zhang J, Davidson C, Walkley SU, Bagel JH, Vite C, Yanjanin NM, Porter FD, Schaffer JE, Ory DS.

J Lipid Res. 2013 Oct;54(10):2800-14. doi: 10.1194/jlr.M040618. Epub 2013 Jul 23.

44.

Postmortem evaluation of 435 cases of intracranial neoplasia in dogs and relationship of neoplasm with breed, age, and body weight.

Song RB, Vite CH, Bradley CW, Cross JR.

J Vet Intern Med. 2013 Sep-Oct;27(5):1143-52. doi: 10.1111/jvim.12136. Epub 2013 Jul 19.

45.

Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.

Roszell BR, Tao JQ, Yu KJ, Gao L, Huang S, Ning Y, Feinstein SI, Vite CH, Bates SR.

PLoS One. 2013 Jul 2;8(7):e67084. doi: 10.1371/journal.pone.0067084. Print 2013.

46.

Features of brain MRI in dogs with treated and untreated mucopolysaccharidosis type I.

Vite CH, Nestrasil I, Mlikotic A, Jens JK, Snella EM, Gross W, Shapiro EG, Kovac V, Provenzale JM, Chen S, Le SQ, Kan SH, Banakar S, Wang RY, Haskins ME, Ellinwood NM, Dickson PI.

Comp Med. 2013 Apr;63(2):163-73.

47.

Electrodiagnostic testing and histopathologic changes confirm peripheral nervous system myelin abnormalities in the feline model of niemann-pick disease type C.

Bagel JH, Sikora TU, Prociuk M, Pesayco JP, Mizisin AP, Shelton GD, Vite CH.

J Neuropathol Exp Neurol. 2013 Mar;72(3):256-62. doi: 10.1097/NEN.0b013e318286587f.

48.

A digital atlas of the dog brain.

Datta R, Lee J, Duda J, Avants BB, Vite CH, Tseng B, Gee JC, Aguirre GD, Aguirre GK.

PLoS One. 2012;7(12):e52140. doi: 10.1371/journal.pone.0052140. Epub 2012 Dec 20.

49.

Amyloid-β metabolism in Niemann-Pick C disease models and patients.

Mattsson N, Olsson M, Gustavsson MK, Kosicek M, Malnar M, Månsson JE, Blomqvist M, Gobom J, Andreasson U, Brinkmalm G, Vite C, Hecimovic S, Hastings C, Blennow K, Zetterberg H, Portelius E.

Metab Brain Dis. 2012 Dec;27(4):573-85. doi: 10.1007/s11011-012-9332-8. Epub 2012 Sep 1.

PMID:
22935999
50.

Identification of the rostral migratory stream in the canine and feline brain.

Malik SZ, Lewis M, Isaacs A, Haskins M, Van Winkle T, Vite CH, Watson DJ.

PLoS One. 2012;7(5):e36016. doi: 10.1371/journal.pone.0036016. Epub 2012 May 11.

Supplemental Content

Support Center